SG Americas Securities LLC boosted its position in shares of Acadia Healthcare Company Inc (NASDAQ:ACHC) by 700.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 35,890 shares of the company’s stock after buying an additional 31,408 shares during the quarter. SG Americas Securities LLC’s holdings in Acadia Healthcare were worth $1,171,000 as of its most recent SEC filing.
A number of other large investors have also recently bought and sold shares of ACHC. State Street Corp lifted its holdings in Acadia Healthcare by 95.2% during the 2nd quarter. State Street Corp now owns 1,998,030 shares of the company’s stock worth $98,667,000 after buying an additional 974,524 shares in the last quarter. Frontier Capital Management Co. LLC raised its position in shares of Acadia Healthcare by 13.2% during the 4th quarter. Frontier Capital Management Co. LLC now owns 2,903,403 shares of the company’s stock valued at $94,738,000 after acquiring an additional 337,961 shares during the last quarter. Pictet Asset Management Ltd. bought a new stake in shares of Acadia Healthcare during the 3rd quarter valued at $11,324,000. Fisher Asset Management LLC bought a new stake in shares of Acadia Healthcare during the 3rd quarter valued at $9,791,000. Finally, Dimensional Fund Advisors LP raised its position in shares of Acadia Healthcare by 11.8% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,662,663 shares of the company’s stock valued at $79,408,000 after acquiring an additional 176,020 shares during the last quarter.
Several analysts have commented on the stock. Cantor Fitzgerald dropped their target price on shares of Acadia Healthcare from $48.00 to $39.00 and set a “neutral” rating for the company in a research report on Tuesday, October 24th. Craig Hallum reiterated a “buy” rating and set a $41.00 target price (down previously from $65.00) on shares of Acadia Healthcare in a research report on Thursday, October 26th. Bank of America dropped their target price on shares of Acadia Healthcare from $60.00 to $52.00 and set a “buy” rating for the company in a research report on Wednesday, October 25th. Deutsche Bank cut shares of Acadia Healthcare from a “buy” rating to a “hold” rating and dropped their target price for the company from $60.00 to $37.00 in a research report on Wednesday, October 25th. Finally, Robert W. Baird cut shares of Acadia Healthcare from an “outperform” rating to a “neutral” rating and dropped their target price for the company from $55.00 to $38.00 in a research report on Wednesday, October 25th. Eight analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $43.92.
Shares of Acadia Healthcare Company Inc (ACHC) opened at $34.24 on Wednesday. The company has a debt-to-equity ratio of 1.30, a current ratio of 1.36 and a quick ratio of 1.36. Acadia Healthcare Company Inc has a 1 year low of $26.92 and a 1 year high of $54.34. The company has a market cap of $2,964.18, a price-to-earnings ratio of 17.38, a P/E/G ratio of 1.14 and a beta of 0.85.
In related news, Director Reeve B. Waud sold 100,000 shares of the company’s stock in a transaction on Friday, December 15th. The shares were sold at an average price of $31.80, for a total value of $3,180,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 11.10% of the stock is owned by corporate insiders.
WARNING: This piece was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be accessed at https://www.dispatchtribunal.com/2018/02/14/sg-americas-securities-llc-boosts-holdings-in-acadia-healthcare-company-inc-achc.html.
Acadia Healthcare Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company Inc (NASDAQ:ACHC).
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.